Who is sponsoring NCT06081205?

NCT06081205 is sponsored by University Hospital, Ioannina.

What drugs are being tested in NCT06081205?

Interventions in NCT06081205: Admission in the Cardiac Intensive Care Unit (CICU).

What condition does NCT06081205 study?

NCT06081205 studies Cardiogenic Shock, Acute Decompensated Heart Failure, Acute Pulmonary Embolism, Acute Myocardial Infarction.

Is NCT06081205 still recruiting?

NCT06081205 is currently recruiting now. Last updated 13 October 2023.

Last reviewed 2023-10-13 · How we verify

NCT06081205

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease

Recruiting now Last updated 13 October 2023

What this trial tests

trial testing Admission in the Cardiac Intensive Care Unit (CICU) in Cardiogenic Shock in 1,000 participants. Currently enrolling.

Timeline

27 April 2023

Primary endpoint
26 April 2026

26 April 2027

Quick facts

Lead sponsor	University Hospital, Ioannina
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	27 April 2023
Primary completion	26 April 2026
Estimated completion	26 April 2027
Sites	1 location across Greece

Drugs / interventions tested

Admission in the Cardiac Intensive Care Unit (CICU)

Conditions studied

Cardiogenic Shock — all drugs for Cardiogenic Shock →
Acute Decompensated Heart Failure — all drugs for Acute Decompensated Heart Failure →
Acute Pulmonary Embolism — all drugs for Acute Pulmonary Embolism →
Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

University Hospital, Ioannina

Who can join

Eligibility, any sex, with Cardiogenic Shock or Acute Decompensated Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a registry of the patients that are admitted to CICU and treated by the Scientific Staff of the 2nd Department of Cardiology, due to an acute cardiovascular disease (acute coronary syndrome, acute heart failure, arrhythmia, pulmonary embolism, cardiac tamponade etc) in order to investigate the clinical characteristics of the patients, their outcome, identify the factors that could predict the in-hospital mortality and compare the results with the predicted by established risk scores. Furthermore, the study will investigate the one-year mortality and also the major adverse cardiac events (MACE - acute myocardial infarction, stroke, or cardiovascular death) will be measured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiogenic Shock

Currently open trials in the same condition.

NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07345559 — Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock · NA · recruiting
NCT07374289 — On Scene ECPR in Ostrava · NA · recruiting
NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
NCT07309029 — Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR · recruiting

Other University Hospital, Ioannina trials

Trials by the same sponsor.

NCT07372521 — Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontro · not yet recruiting
NCT05734248 — Fractional Laser Drug Delivery of a Local Anesthetic · NA · completed
NCT06115213 — The North Kynouria Project · NA · unknown
NCT04787510 — COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection · completed
NCT04657445 — EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06081205 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ioannina
Last refreshed: 13 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06081205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing